The demand for new and more versatile diagnostics is increasing due to the knowledge expansion on biomarkers and their roles in diseases. Fulfilling this changing need for diagnostics - medical device technology is INFORMM's major focus which entails lateral flow assay (LFA) and biosensors.

Recent advances in chemistry and biotechnology have allowed the expansion of innovative new designs of tools and reagents for diagnostics. INFORMM has a group of researchers who are passionate about contributing to this area of diagnostics.

Therapeutic antibodies represent an important class of newly introduced drugs and have been particularly successful in cancer therapy and the treatment of inflammatory diseases. We have a working group at INFORMM developing antibodies in combating diseases.

Aptamers are short sequences of artificial DNA, RNA, XNA, or peptides that bind a specific target molecule or family of target molecules sometimes classified as chemical antibodies. We have a group at INFORMM actively isolating aptamers and investigating their effect on parasitic diseases and cancer. 

Natural products have long been studied for their medicinal properties on human health. At INFORMM, we have working groups on natural products as anti-cancer and as health supplements. We also used computational analysis to predict natural product properties.

Various technological strategies have been implemented for the development of vaccines, both prophylactic and therapeutic. Our group at INFORMM is currently exploring both strategies in combating infectious and non-communicable diseases.